ARCHIVES

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

This article is from The Cancer Letter archive.

Vol. 04 No. 33 | August 18, 1978

Download PDF Visit The Full Archive

Related Articles

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

Gallo To Say, For Now, DeVita Says: Core Grants Face Big Cut

March 18, 1988

PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial.

November 3, 2006

Number of Cancer Deaths Rise Slightly Due To Population Growth And Aging.

February 22, 2008

NIH closes Meeting of BSC Chairmen, Violation of Open Meetings Law Alleged

August 5, 1994

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011